Madrigal Pharmaceuticals
MDGL
#2088
Rank
A$13.30 B
Marketcap
A$572.74
Share price
-4.45%
Change (1 day)
-33.51%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): A-$8.68

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$8.93. In 2025 the company made an earnings per share (EPS) of A-$16.15 an increase over its 2024 EPS that were of A-$33.40.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$8.68-46.28%
2025A-$16.15-51.65%
2024A-$33.40
2022A-$26.0317.93%
2021A-$22.0711.61%
2020A-$19.78140.18%
2019A-$8.23146.61%
2018A-$3.34-12.99%
2017A-$3.84-91.03%
2016A-$42.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.29-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.44-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA